Researchers has significantly improved its progress of the novel treatment for cardiac amyloidosis, leveraging the compound. Initial clinical information suggests promising benefits for patients diagnosed with a https://attrcm023228.shotblogs.com/bridgebio-advances-amyloidosis-treatment-through-the-drug-56298992